                         SEQUENCE LISTING

<110>  National University of Singapore
 
<120>  METHOD AND SYSTEM FOR IDENTIFYING AND VALIDATING SHARED

<130>  S61013313

<160>  67    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MARK3 splice variant

<400>  1

Arg Asn Met Ser Phe Arg Phe Ile Lys 
1               5                   


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EBV peptide sequence

<400>  2

Ser Ser Cys Ser Ser Cys Pro Leu Ser Lys 
1               5                   10  


<210>  3
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MARK3 forward primer

<400>  3
tcccatgaag ccacaccatt g                                                 21


<210>  4
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MARK3 reverse primer

<400>  4
agcgtaggga tcgaggcttt g                                                 21


<210>  5
<211>  258
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Exon 23

<400>  5
cactattcct gatcagagaa ctccagttgc ttcaacacac agtatcagta gtgcagccac       60

cccagatcga atccgcttcc caagaggcac tgccagtcgt agcactttcc acggccagcc      120

ccgggaacgg cgaaccgcaa catataatgg ccctcctgcc tctcccagcc tgtcccatga      180

agccacacca ttgtcccaga ctcgaagccg aggctccact aatctcttta gtaaattaac      240

ttcaaaactc acaaggag                                                    258


<210>  6
<211>  948
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Exon 26

<400>  6
tcgcaatgta tctgctgagc aaaaagatga aaacaaagaa gcaaagcctc gatccctacg       60

cttcacctgg agcatgaaaa ccactagttc aatggatccc ggggacatga tgcgggaaat      120

ccgcaaagtg ttggacgcca ataactgcga ctatgagcag agggagcgct tcttgctctt      180

ctgcgtccac ggagatgggc acgcggagaa cctcgtgcag tgggaaatgg aagtgtgcaa      240

gctgccaaga ctgtctctga acggggtccg gtttaagcgg atatcgggga catccatagc      300

cttcaaaaat attgcttcca aaattgccaa tgagctaaag ctgtaaccca gtgattatga      360

tgtaaattaa gtagcaatta aagtgttttc ctgaacactg atggaaatgt atagaataat      420

atttaggcaa taacgtctgc atcttctaaa tcatgaaatt aaagtctgag gacgagagca      480

cgcctgggag cgaaagctgg ccttttttct acgaatgcac tacattaaag atgtgcaacc      540

tatgcgcccc ctgccctact tccgttaccc tgagagtcgg tgtgtggccc catctccatg      600

tgcctcccgt ctgggtgggt gtgagagtgg acggtatgtg tgtgaagtgg tgtatatgga      660

agcatctccc tacactggca gccagtcatt actagtacct ctgcgggaga tcatccggtg      720

ctaaaacatt acagttgcca aggaggaaaa tactgaatga ctgctaagaa ttaaccttaa      780

gaccagttca tagttaatac aggtttacag ttcatgcctg tggttttgtg tttgttgttt      840

tgtgtttttt tagtgcaaaa ggtttaaatt tatagttgtg aacattgctt gtgtgtgttt      900

ttctaagtag attcacaaga taattaaaaa ttcacttttt ctcagtaa                   948


<210>  7
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Exon 24

<400>  7
aaacatgtca ttcaggttta tcaaaag                                           27


<210>  8
<211>  45
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Exon 25

<400>  8
gcttccaact gaatatgaga ggaacgggag atatgagggc tcaag                       45


<210>  9
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TRAC primer

<400>  9
gaccagcttg acatcacag                                                    19


<210>  10
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TRAC primer

<400>  10
ctcaggcagt atctggagtc attg                                              24


<210>  11
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TRAC PCR1

<400>  11
tgctgttgtt gaaggcgttt g                                                 21


<210>  12
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TRAC PCR2

<400>  12
tgttgctctt gaagtccata g                                                 21


<210>  13
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TRBC PCR1

<400>  13
cccactgtgc acctccttc                                                    19


<210>  14
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TRBC PCR2

<400>  14
ttctgatggc tcaaacacag                                                   20


<210>  15
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TRAV6*01 AA sequence

<400>  15

Met Glu Ser Phe Leu Gly Gly Val Leu Leu Ile Leu Trp Leu Gln Val 
1               5                   10                  15      


Asp Trp Val Lys Ser Gln Lys Ile Glu Gln Asn Ser Glu Ala Leu Asn 
            20                  25                  30          


Ile Gln Glu Gly Lys Thr Ala Thr Leu Thr Cys Asn Tyr Thr Asn Tyr 
        35                  40                  45              


Ser Pro Ala Tyr Leu Gln Trp Tyr Arg Gln Asp Pro Gly Arg Gly Pro 
    50                  55                  60                  


Val Phe Leu Leu Leu Ile Arg Glu Asn Glu Lys Glu Lys Arg Lys Glu 
65                  70                  75                  80  


Arg Leu Lys Val Thr Phe Asp Thr Thr Leu Lys Gln Ser Leu Phe His 
                85                  90                  95      


Ile Thr Ala Ser Gln Pro Ala Asp Ser Ala Thr Tyr Leu 
            100                 105                 


<210>  16
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TRAJ9*01 AA sequence

<400>  16

Gly Ala Gly Thr Arg Leu Phe Val Lys Ala Asn 
1               5                   10      


<210>  17
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR1 AA sequence

<400>  17

Asn Tyr Ser Pro Ala Tyr 
1               5       


<210>  18
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR2 AA sequence

<400>  18

Ile Arg Glu Asn Glu Lys Glu 
1               5           


<210>  19
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CDR3 nucleotide sequence

<400>  19
tgtgctccgt atactggagg cttcaaaact atcttt                                 36


<210>  20
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR3 AA sequence

<400>  20

Cys Ala Pro Tyr Thr Gly Gly Phe Lys Thr Ile Phe 
1               5                   10          


<210>  21
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MARK3 TRA variable region AA sequence

<400>  21

Met Glu Ser Phe Leu Gly Gly Val Leu Leu Ile Leu Trp Leu Gln Val 
1               5                   10                  15      


Asp Trp Val Lys Ser Gln Lys Ile Glu Gln Asn Ser Glu Ala Leu Asn 
            20                  25                  30          


Ile Gln Glu Gly Lys Thr Ala Thr Leu Thr Cys Asn Tyr Thr Asn Tyr 
        35                  40                  45              


Ser Pro Ala Tyr Leu Gln Trp Tyr Arg Gln Asp Pro Gly Arg Gly Pro 
    50                  55                  60                  


Val Phe Leu Leu Leu Ile Arg Glu Asn Glu Lys Glu Lys Arg Lys Glu 
65                  70                  75                  80  


Arg Leu Lys Val Thr Phe Asp Thr Thr Leu Lys Gln Ser Leu Phe His 
                85                  90                  95      


Ile Thr Ala Ser Gln Pro Ala Asp Ser Ala Thr Tyr Leu Cys Ala Pro 
            100                 105                 110         


Tyr Thr Gly Gly Phe Lys Thr Ile Phe Gly Ala Gly Thr Arg Leu Phe 
        115                 120                 125             


Val Lys Ala Asn 
    130         


<210>  22
<211>  272
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MARK3 TRA AA sequence

<400>  22

Met Glu Ser Phe Leu Gly Gly Val Leu Leu Ile Leu Trp Leu Gln Val 
1               5                   10                  15      


Asp Trp Val Lys Ser Gln Lys Ile Glu Gln Asn Ser Glu Ala Leu Asn 
            20                  25                  30          


Ile Gln Glu Gly Lys Thr Ala Thr Leu Thr Cys Asn Tyr Thr Asn Tyr 
        35                  40                  45              


Ser Pro Ala Tyr Leu Gln Trp Tyr Arg Gln Asp Pro Gly Arg Gly Pro 
    50                  55                  60                  


Val Phe Leu Leu Leu Ile Arg Glu Asn Glu Lys Glu Lys Arg Lys Glu 
65                  70                  75                  80  


Arg Leu Lys Val Thr Phe Asp Thr Thr Leu Lys Gln Ser Leu Phe His 
                85                  90                  95      


Ile Thr Ala Ser Gln Pro Ala Asp Ser Ala Thr Tyr Leu Cys Ala Pro 
            100                 105                 110         


Tyr Thr Gly Gly Phe Lys Thr Ile Phe Gly Ala Gly Thr Arg Leu Phe 
        115                 120                 125             


Val Lys Ala Asn Ile Gln Asn Pro Asp Pro Ala Val Tyr Gln Leu Arg 
    130                 135                 140                 


Asp Ser Lys Ser Ser Asp Lys Ser Val Cys Leu Phe Thr Asp Phe Asp 
145                 150                 155                 160 


Ser Gln Thr Asn Val Ser Gln Ser Lys Asp Ser Asp Val Tyr Ile Thr 
                165                 170                 175     


Asp Lys Thr Val Leu Asp Met Arg Ser Met Asp Phe Lys Ser Asn Ser 
            180                 185                 190         


Ala Val Ala Trp Ser Asn Lys Ser Asp Phe Ala Cys Ala Asn Ala Phe 
        195                 200                 205             


Asn Asn Ser Ile Ile Pro Glu Asp Thr Phe Phe Pro Ser Pro Glu Ser 
    210                 215                 220                 


Ser Cys Asp Val Lys Leu Val Glu Lys Ser Phe Glu Thr Asp Thr Asn 
225                 230                 235                 240 


Leu Asn Phe Gln Asn Leu Ser Val Ile Gly Phe Arg Ile Leu Leu Leu 
                245                 250                 255     


Lys Val Ala Gly Phe Asn Leu Leu Met Thr Leu Arg Leu Trp Ser Ser 
            260                 265                 270         


<210>  23
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TRBV7-9*01 AA sequence

<400>  23

Met Gly Thr Ser Leu Leu Cys Trp Met Ala Leu Cys Leu Leu Gly Ala 
1               5                   10                  15      


Asp His Ala Asp Thr Gly Val Ser Gln Asn Pro Arg His Lys Ile Thr 
            20                  25                  30          


Lys Arg Gly Gln Asn Val Thr Phe Arg Cys Asp Pro Ile Ser Glu His 
        35                  40                  45              


Asn Arg Leu Tyr Trp Tyr Arg Gln Thr Leu Gly Gln Gly Pro Glu Phe 
    50                  55                  60                  


Leu Thr Tyr Phe Gln Asn Glu Ala Gln Leu Glu Lys Ser Arg Leu Leu 
65                  70                  75                  80  


Ser Asp Arg Phe Ser Ala Glu Arg Pro Lys Gly Ser Phe Ser Thr Leu 
                85                  90                  95      


Glu Ile Gln Arg Thr Glu Gln Gly Asp Ser Ala Met Tyr Leu 
            100                 105                 110 


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TRAJ1-2*01 AA sequence

<400>  24

Gly Ser Gly Thr Arg Leu Thr Val Val 
1               5                   


<210>  25
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR1 AA sequence

<400>  25

Ser Glu His Asn Arg 
1               5   


<210>  26
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR2 AA sequence

<400>  26

Phe Gln Asn Glu Ala 
1               5   


<210>  27
<211>  42
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CDR3 nucleotide sequence

<400>  27
tgtgccagca gctccccccg ggttggctat ggctacacct tc                          42


<210>  28
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR3 AA sequence

<400>  28

Cys Ala Ser Ser Ser Pro Arg Val Gly Tyr Gly Tyr Thr Phe 
1               5                   10                  


<210>  29
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MARK3 TRB variable region AA sequence

<400>  29

Met Gly Thr Ser Leu Leu Cys Trp Met Ala Leu Cys Leu Leu Gly Ala 
1               5                   10                  15      


Asp His Ala Asp Thr Gly Val Ser Gln Asn Pro Arg His Lys Ile Thr 
            20                  25                  30          


Lys Arg Gly Gln Asn Val Thr Phe Arg Cys Asp Pro Ile Ser Glu His 
        35                  40                  45              


Asn Arg Leu Tyr Trp Tyr Arg Gln Thr Leu Gly Gln Gly Pro Glu Phe 
    50                  55                  60                  


Leu Thr Tyr Phe Gln Asn Glu Ala Gln Leu Glu Lys Ser Arg Leu Leu 
65                  70                  75                  80  


Ser Asp Arg Phe Ser Ala Glu Arg Pro Lys Gly Ser Phe Ser Thr Leu 
                85                  90                  95      


Glu Ile Gln Arg Thr Glu Gln Gly Asp Ser Ala Met Tyr Leu Cys Ala 
            100                 105                 110         


Ser Ser Ser Pro Arg Val Gly Tyr Gly Tyr Thr Phe Gly Ser Gly Thr 
        115                 120                 125             


Arg Leu Thr Val Val 
    130             


<210>  30
<211>  312
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MARK3 TRB AA sequence

<400>  30

Met Gly Thr Ser Leu Leu Cys Trp Met Ala Leu Cys Leu Leu Gly Ala 
1               5                   10                  15      


Asp His Ala Asp Thr Gly Val Ser Gln Asn Pro Arg His Lys Ile Thr 
            20                  25                  30          


Lys Arg Gly Gln Asn Val Thr Phe Arg Cys Asp Pro Ile Ser Glu His 
        35                  40                  45              


Asn Arg Leu Tyr Trp Tyr Arg Gln Thr Leu Gly Gln Gly Pro Glu Phe 
    50                  55                  60                  


Leu Thr Tyr Phe Gln Asn Glu Ala Gln Leu Glu Lys Ser Arg Leu Leu 
65                  70                  75                  80  


Ser Asp Arg Phe Ser Ala Glu Arg Pro Lys Gly Ser Phe Ser Thr Leu 
                85                  90                  95      


Glu Ile Gln Arg Thr Glu Gln Gly Asp Ser Ala Met Tyr Leu Cys Ala 
            100                 105                 110         


Ser Ser Ser Pro Arg Val Gly Tyr Gly Tyr Thr Phe Gly Ser Gly Thr 
        115                 120                 125             


Arg Leu Thr Val Val Glu Asp Leu Asn Lys Val Phe Pro Pro Glu Val 
    130                 135                 140                 


Ala Val Phe Glu Pro Ser Glu Ala Glu Ile Ser His Thr Gln Lys Ala 
145                 150                 155                 160 


Thr Leu Val Cys Leu Ala Thr Gly Phe Phe Pro Asp His Val Glu Leu 
                165                 170                 175     


Ser Trp Trp Val Asn Gly Lys Glu Val His Ser Gly Val Ser Thr Asp 
            180                 185                 190         


Pro Gln Pro Leu Lys Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr Cys 
        195                 200                 205             


Leu Ser Ser Arg Leu Arg Val Ser Ala Thr Phe Trp Gln Asn Pro Arg 
    210                 215                 220                 


Asn His Phe Arg Cys Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp 
225                 230                 235                 240 


Glu Trp Thr Gln Asp Arg Ala Lys Pro Val Thr Gln Ile Val Ser Ala 
                245                 250                 255     


Glu Ala Trp Gly Arg Ala Asp Cys Gly Phe Thr Ser Val Ser Tyr Gln 
            260                 265                 270         


Gln Gly Val Leu Ser Ala Thr Ile Leu Tyr Glu Ile Leu Leu Gly Lys 
        275                 280                 285             


Ala Thr Leu Tyr Ala Val Leu Val Ser Ala Leu Val Leu Met Ala Met 
    290                 295                 300                 


Val Lys Arg Lys Asp Ser Arg Gly 
305                 310         


<210>  31
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  NBPF9 splice variant antigen

<400>  31

Ser Ser Phe Tyr Ala Leu Glu Glu Lys 
1               5                   


<210>  32
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PARD3 splice variant antigen

<400>  32

Ser Gln Leu Asp Phe Val Lys Thr Arg Lys 
1               5                   10  


<210>  33
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZC3HAV splice variant antigen

<400>  33

Leu Thr Met Ala Val Lys Ala Glu Lys 
1               5                   


<210>  34
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  YAF2 splice variant antigen

<400>  34

Val Ile Val Ser Ala Ser Arg Thr Lys 
1               5                   


<210>  35
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CAMKK1 splice variant antigen

<400>  35

Val Thr Ser Pro Ser Arg Arg Ser Lys 
1               5                   


<210>  36
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  LRR1 splice variant antigen

<400>  36

Ser Leu Pro Arg Phe Gly Tyr Arg Lys 
1               5                   


<210>  37
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZNF670 splice variant antigen

<400>  37

Ser Cys Val Ser Pro Ser Ser Glu Leu Lys 
1               5                   10  


<210>  38
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GRINA splice variant antigen

<400>  38

Ser Ile Arg Gln Ala Phe Ile Arg Lys 
1               5                   


<210>  39
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CAMKK1 skipped exon

<400>  39
tgtttgacct cctgagaaag gg                                                22


<210>  40
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CAMKK1F

<400>  40
gaagctggac cacgtgaatg tg                                                22


<210>  41
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CAMKK1R

<400>  41
agtactcgag gcccaggatg ac                                                22


<210>  42
<211>  722
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LRR1 skipped exon

<400>  42
gccatttcca gcagtttaaa aggtttcctt tcagctatga gactggctca tagaggctgt       60

aatgttgata caccagtttc aacgctcaca ccagtgaaga cttcagaatt tgaaaacttt      120

aaaactaaaa tggttatcac atccaaaaaa gactatcctc taagtaagaa ttttccatat      180

tccttggaac atcttcagac ttcttactgt gggcttgtcc gagttgatat gcgtatgctt      240

tgcttaaaaa gccttaggaa attagacttg agtcacaacc atataaaaaa gcttccagct      300

acaattggag acctcataca ccttcaagaa cttaacctga atgacaatca cttggagtca      360

tttagtgtag ccttgtgtca ttctacactc cagaagtcac ttcggagttt ggacctcagc      420

aagaacaaaa tcaaggcact ccctgtgcag ttttgccagc tccaggaact taagaattta      480

aaacttgacg ataatgaatt gattcaattt ccttgcaaga taggacaact aataaacctt      540

cgctttttgt cagcagctcg aaataagctt ccatttttgc ctagtgaatt tagaaattta      600

tcccttgaat acttggatct ttttggaaat acttttgaac aaccaaaagt ccttccagta      660

ataaagctgc aagcaccatt aactttattg gaatcttctg cacgaaccat attacataat      720

ag                                                                     722


<210>  43
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LRR1F

<400>  43
tgaggggaaa gccactgttc                                                   20


<210>  44
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LRR1R

<400>  44
ttcagacaga atcttccaca aacac                                             25


<210>  45
<211>  98
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ZNF670 skipped exon

<400>  45
ccatgtgaag atgtgcttgc ttcccctttg ccttctgcca tgattctaag tttcctgagg       60

cctccccaga agcagaagca tgtaaagccc acagaacc                               98


<210>  46
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ZNF670F

<400>  46
ttcattccaa aaagtgatgc tgag                                              24


<210>  47
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ZNF670R

<400>  47
caacatggaa gaacaatctt cctttc                                            26


<210>  48
<211>  440
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GRINA1 skipped exon

<400>  48
gtgggtaggg gcatctccaa ggcggtgggg gctgtggctc ccagcggatg actctgagcg       60

gctccttccc caggtgttcc tagtgctgac cttgcagctg tcggtgaccc tgtccacggt      120

gtctgtgttc acttttgttg cggaggtgaa gggctttgtc cgggagaatg tctggaccta      180

ctatgtctcc tatgctgtct tcttcatctc tctcatcgtc ctcagctgtt gtggggactt      240

ccggcgaaag cacccctgga accttgttgc actggtaacc cccaaacctg agcctctgtg      300

cctgggtccg gccatgcagt cccacacgcc cactcttccg ggcctggtca ccgtggttct      360

ccttgtgctc atgaggcagg ggccggcagg ggtggcatgg gggcacacac ccaaggtcag      420

cctgtgtctc ccaactgcag                                                  440


<210>  49
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GRINAF

<400>  49
ggtcccccat cctactatga caac                                              24


<210>  50
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GRINAR

<400>  50
gaatggcgaa gatgaagagc ac                                                22


<210>  51
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  LRR1 splice variant antigen

<400>  51

Ser Tyr His Ser Ile Pro Ser Leu Pro Arg Phe 
1               5                   10      


<210>  52
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MZF1 spliced variant antigen

<400>  52

Lys Trp Pro Pro Ala Thr Glu Thr Leu 
1               5                   


<210>  53
<211>  466
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MZF1 splice variant antigen

<400>  53
gtgagtgagt gtccacgagt ggggttcagg actggagcat catccagctc ggcctcaccc       60

tgggcagcac cacgctttgc cagacacacg ttctcccttg tggtacagaa gtggccacct      120

gcaacagaga ccctgtgcaa ggctgcccag ggcagaggga ttccagggcc agactcccca      180

gcccattcct gcatcacctg cagtcacgtg gacataggag ctgcaggcta ggggaatatg      240

gggaaggtac tggaaggcca cgatgtcaga gcaggggagg gactgcaggt ggtcccttca      300

ttctttgctc agggcctagg ggaggtaggt ccttggagga cctagtcagt aggtatttac      360

aaggcaggcc cctgggatcc tacagtggga tgggcaccca caaaccccag gttgcggcca      420

gccttactct ctggtaggac ttctgatggt gggggcacct ccccag                     466


<210>  54
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MZF1F

<400>  54
gcactgcccc ctgagatcca g                                                 21


<210>  55
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MZF1R

<400>  55
ctttcacctg caggcccagt g                                                 21


<210>  56
<211>  348
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Normal associated DNA sequence of CAMKK1

<400>  56
gtcctggatg acccagctga ggacaacctc tatttggtgt ttgacctcct gagaaagggg       60

cccgtcatgg aagtgccctg tgacaagccc ttctcggagg agcaagctcg cctctacctg      120

cgggacgtca tcctgggcct cgagtacttg cactgccaga agatcgtcca cagggacatc      180

aagccatcca acctgctcct gggggatgat gggcacgtga agatcgccga ctttggcgtc      240

agcaaccagt ttgaggggaa cgacgctcag ctgtccagca cggcgggaac cccagcattc      300

atggcccccg aggccatttc tgattccggc cagagcttca gtgggaag                   348


<210>  57
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Normal protein sequence of CAMKK1

<400>  57

Val Leu Asp Asp Pro Ala Glu Asp Asn Leu Tyr Leu Val Phe Asp Leu 
1               5                   10                  15      


Leu Arg Lys Gly Pro Val Met Glu Val Pro Cys Asp Lys Pro Phe Ser 
            20                  25                  30          


Glu Glu Gln Ala Arg Leu Tyr Leu Arg Asp Val Ile Leu Gly Leu Glu 
        35                  40                  45              


Tyr Leu His Cys Gln Lys Ile Val His Arg Asp Ile Lys Pro Ser Asn 
    50                  55                  60                  


Leu Leu Leu Gly Asp Asp Gly His Val Lys Ile Ala Asp Phe Gly Val 
65                  70                  75                  80  


Ser Asn Gln Phe Glu Gly Asn Asp Ala Gln Leu Ser Ser Thr Ala Gly 
                85                  90                  95      


Thr Pro Ala Phe Met Ala Pro Glu Ala Ile Ser Asp Ser Gly Gln Ser 
            100                 105                 110         


Phe Ser Gly Lys 
        115     


<210>  58
<211>  326
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Tumour associated DNA sequence of CAMKK1

<400>  58
gtcctggatg acccagctga ggacaacctc tatttgggcc cgtcatggaa gtgccctgtg       60

acaagccctt ctcggaggag caagctcgcc tctacctgcg ggacgtcatc ctgggcctcg      120

agtacttgca ctgccagaag atcgtccaca gggacatcaa gccatccaac ctgctcctgg      180

gggatgatgg gcacgtgaag atcgccgact ttggcgtcag caaccagttt gaggggaacg      240

acgctcagct gtccagcacg gcgggaaccc cagcattcat ggcccccgag gccatttctg      300

attccggcca gagcttcagt gggaag                                           326


<210>  59
<211>  65
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Tumour associated protein sequence of CAMKK1

<400>  59

Val Leu Asp Asp Pro Ala Glu Asp Asn Leu Tyr Leu Gly Pro Ser Trp 
1               5                   10                  15      


Lys Cys Pro Val Thr Ser Pro Ser Arg Arg Ser Lys Leu Ala Ser Thr 
            20                  25                  30          


Cys Gly Thr Ser Ser Trp Ala Ser Ser Thr Cys Thr Ala Arg Arg Ser 
        35                  40                  45              


Ser Thr Gly Thr Ser Ser His Pro Thr Cys Ser Trp Gly Met Met Gly 
    50                  55                  60                  


Thr 
65  


<210>  60
<211>  993
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Normal associated DNA sequence of LRR1

<400>  60
gagcctcctg tggatatctg tctaagtaag gccatttcca gcagtttaaa aggtttcctt       60

tcagctatga gactggctca tagaggctgt aatgttgata caccagtttc aacgctcaca      120

ccagtgaaga cttcagaatt tgaaaacttt aaaactaaaa tggttatcac atccaaaaaa      180

gactatcctc taagtaagaa ttttccatat tccttggaac atcttcagac ttcttactgt      240

gggcttgtcc gagttgatat gcgtatgctt tgcttaaaaa gccttaggaa attagacttg      300

agtcacaacc atataaaaaa gcttccagct acaattggag acctcataca ccttcaagaa      360

cttaacctga atgacaatca cttggagtca tttagtgtag ccttgtgtca ttctacactc      420

cagaagtcac ttcggagttt ggacctcagc aagaacaaaa tcaaggcact ccctgtgcag      480

ttttgccagc tccaggaact taagaattta aaacttgacg ataatgaatt gattcaattt      540

ccttgcaaga taggacaact aataaacctt cgctttttgt cagcagctcg aaataagctt      600

ccatttttgc ctagtgaatt tagaaattta tcccttgaat acttggatct ttttggaaat      660

acttttgaac aaccaaaagt ccttccagta ataaagctgc aagcaccatt aactttattg      720

gaatcttctg cacgaaccat attacataat aggattccat atggctctca tatcattcca      780

ttccatctct gccaagattt ggataccgca aaaatttgtg tttgtggaag attctgtctg      840

aactctttca ttcaaggaac tactaccatg aatctgcatt ctgttgccca cactgtggtc      900

ttagtagata atttgggtgg tactgaagca cctattatct cttatttctg ttctctaggc      960

tgttatgtta attcctctga tatgttaaag taa                                   993


<210>  61
<211>  330
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Normal protein sequence of LRR1

<400>  61

Glu Pro Pro Val Asp Ile Cys Leu Ser Lys Ala Ile Ser Ser Ser Leu 
1               5                   10                  15      


Lys Gly Phe Leu Ser Ala Met Arg Leu Ala His Arg Gly Cys Asn Val 
            20                  25                  30          


Asp Thr Pro Val Ser Thr Leu Thr Pro Val Lys Thr Ser Glu Phe Glu 
        35                  40                  45              


Asn Phe Lys Thr Lys Met Val Ile Thr Ser Lys Lys Asp Tyr Pro Leu 
    50                  55                  60                  


Ser Lys Asn Phe Pro Tyr Ser Leu Glu His Leu Gln Thr Ser Tyr Cys 
65                  70                  75                  80  


Gly Leu Val Arg Val Asp Met Arg Met Leu Cys Leu Lys Ser Leu Arg 
                85                  90                  95      


Lys Leu Asp Leu Ser His Asn His Ile Lys Lys Leu Pro Ala Thr Ile 
            100                 105                 110         


Gly Asp Leu Ile His Leu Gln Glu Leu Asn Leu Asn Asp Asn His Leu 
        115                 120                 125             


Glu Ser Phe Ser Val Ala Leu Cys His Ser Thr Leu Gln Lys Ser Leu 
    130                 135                 140                 


Arg Ser Leu Asp Leu Ser Lys Asn Lys Ile Lys Ala Leu Pro Val Gln 
145                 150                 155                 160 


Phe Cys Gln Leu Gln Glu Leu Lys Asn Leu Lys Leu Asp Asp Asn Glu 
                165                 170                 175     


Leu Ile Gln Phe Pro Cys Lys Ile Gly Gln Leu Ile Asn Leu Arg Phe 
            180                 185                 190         


Leu Ser Ala Ala Arg Asn Lys Leu Pro Phe Leu Pro Ser Glu Phe Arg 
        195                 200                 205             


Asn Leu Ser Leu Glu Tyr Leu Asp Leu Phe Gly Asn Thr Phe Glu Gln 
    210                 215                 220                 


Pro Lys Val Leu Pro Val Ile Lys Leu Gln Ala Pro Leu Thr Leu Leu 
225                 230                 235                 240 


Glu Ser Ser Ala Arg Thr Ile Leu His Asn Arg Ile Pro Tyr Gly Ser 
                245                 250                 255     


His Ile Ile Pro Phe His Leu Cys Gln Asp Leu Asp Thr Ala Lys Ile 
            260                 265                 270         


Cys Val Cys Gly Arg Phe Cys Leu Asn Ser Phe Ile Gln Gly Thr Thr 
        275                 280                 285             


Thr Met Asn Leu His Ser Val Ala His Thr Val Val Leu Val Asp Asn 
    290                 295                 300                 


Leu Gly Gly Thr Glu Ala Pro Ile Ile Ser Tyr Phe Cys Ser Leu Gly 
305                 310                 315                 320 


Cys Tyr Val Asn Ser Ser Asp Met Leu Lys 
                325                 330 


<210>  62
<211>  271
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Tumour associated DNA sequence of LRR1

<400>  62
gagcctcctg tggatatctg tctaagtaag gattccatat ggctctcata tcattccatt       60

ccatctctgc caagatttgg ataccgcaaa aatttgtgtt tgtggaagat tctgtctgaa      120

ctctttcatt caaggaacta ctaccatgaa tctgcattct gttgcccaca ctgtggtctt      180

agtagataat ttgggtggta ctgaagcacc tattatctct tatttctgtt ctctaggctg      240

ttatgttaat tcctctgata tgttaaagta a                                     271


<210>  63
<211>  62
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Tumour associated protein sequence of LRR1

<400>  63

Glu Pro Pro Val Asp Ile Cys Leu Ser Lys Asp Ser Ile Trp Leu Ser 
1               5                   10                  15      


Tyr His Ser Ile Pro Ser Leu Pro Arg Phe Gly Tyr Arg Lys Asn Leu 
            20                  25                  30          


Cys Leu Trp Lys Ile Leu Ser Glu Leu Phe His Ser Arg Asn Tyr Tyr 
        35                  40                  45              


His Glu Ser Ala Phe Cys Cys Pro His Cys Gly Leu Ser Arg 
    50                  55                  60          


<210>  64
<211>  515
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Normal associated DNA sequence of ZNF670

<400>  64
ttttgtcttc ttatcttact gaagacattt tgccagagca gggcctgcaa gtttcattcc       60

aaaaagtgat gctgagaaga tatgaaagat gttgtcttga gaaattacgc ttaaggaatg      120

actgggaaat tgtggccatg tgaagatgtg cttgcttccc ctttgccttc tgccatgatt      180

ctaagtttcc tgaggcctcc ccagaagcag aagcatgtaa agcccacaga accggtccag      240

tcgtcgacca tcgagctgct ttgaagaccc tgcggaggtt ccgtcgctgc ttgaacacag      300

tgcctggact ccctgctccg tgaggcgaat ttacaccggg tccagctgcg tcagcccgag      360

ttctgaatta aaacatgcct cccacagaat ctatttctga tgaatatgaa aggaagattg      420

ttcttccatg ttggttttta ttgagatatc tctttttttc ccttttcatt tggttgtcct      480

aactccatga atagaaaaga aaatgtatta attca                                 515


<210>  65
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Normal protein sequence of ZNF670

<400>  65

Leu Ser Ser Tyr Leu Thr Glu Asp Ile Leu Pro Glu Gln Gly Leu Gln 
1               5                   10                  15      


Val Ser Phe Gln Lys Val Met Leu Arg Arg Tyr Glu Arg Cys Cys Leu 
            20                  25                  30          


Glu Lys Leu Arg Leu Arg Asn Asp Trp Glu Ile Val Ala Met 
        35                  40                  45      


<210>  66
<211>  417
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Tumour associated DNA sequence of ZNF670

<400>  66
ttttgtcttc ttatcttact gaagacattt tgccagagca gggcctgcaa gtttcattcc       60

aaaaagtgat gctgagaaga tatgaaagat gttgtcttga gaaattacgc ttaaggaatg      120

actgggaaat tgtggggtcc agtcgtcgac catcgagctg ctttgaagac cctgcggagg      180

ttccgtcgct gcttgaacac agtgcctgga ctccctgctc cgtgaggcga atttacaccg      240

ggtccagctg cgtcagcccg agttctgaat taaaacatgc ctcccacaga atctatttct      300

gatgaatatg aaaggaagat tgttcttcca tgttggtttt tattgagata tctctttttt      360

tcccttttca tttggttgtc ctaactccat gaatagaaaa gaaaatgtat taattca         417


<210>  67
<211>  99
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Tumour associated protein sequence of ZNF670

<400>  67

Leu Ser Ser Tyr Leu Thr Glu Asp Ile Leu Pro Glu Gln Gly Leu Gln 
1               5                   10                  15      


Val Ser Phe Gln Lys Val Met Leu Arg Arg Tyr Glu Arg Cys Cys Leu 
            20                  25                  30          


Glu Lys Leu Arg Leu Arg Asn Asp Trp Glu Ile Val Gly Ser Ser Arg 
        35                  40                  45              


Arg Pro Ser Ser Cys Phe Glu Asp Pro Ala Glu Val Pro Ser Leu Leu 
    50                  55                  60                  


Glu His Ser Ala Trp Thr Pro Cys Ser Val Arg Arg Ile Tyr Thr Gly 
65                  70                  75                  80  


Ser Ser Cys Val Ser Pro Ser Ser Glu Leu Lys His Ala Ser His Arg 
                85                  90                  95      


Ile Tyr Phe 
            


